WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (NASDAQ: NEOL), today announced its second quarter 2007 financial results. For the second quarter ended June 30, 2007, NEOPHARM reported a net loss of $3.6 million, or ($0.13) per diluted share, as compared to a loss of $9.8 million, or ($0.35) per share, for the same period last year, which represents a $6.2 million, or 63%, reduction. This reduction was driven primarily by continued reduction of personnel costs and aggressive cost reduction initiatives for non-personnel expenses.
